RxSight (RXST) Capital Expenditures (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.48% |
| Dec 31, 2025 | -193.00% |
| Sep 30, 2025 | 851.69% |
| Jun 30, 2025 | -156.52% |
| Mar 31, 2025 | -88.61% |
| Dec 31, 2024 | 2,977.44% |
| Sep 30, 2024 | 243.86% |
| Jun 30, 2024 | -133.24% |
| Mar 31, 2024 | -78.44% |
| Dec 31, 2023 | -43.48% |
| Sep 30, 2023 | 1,789.26% |
| Jun 30, 2023 | -42.47% |
| Mar 31, 2023 | 114.95% |
| Dec 31, 2022 | -398.62% |
| Sep 30, 2022 | -46.35% |
| Jun 30, 2022 | 192.16% |
| Mar 31, 2022 | 1.37% |
| Dec 31, 2021 | 43.70% |
| Sep 30, 2021 | -69.14% |
| Jun 30, 2021 | 65.26% |
| Mar 31, 2021 | -78.60% |
| Dec 31, 2020 | 296.21% |